“…The use of hucMSC-EV has shown beneficial effects in a variety of diseases, such as lung disease ( Willis et al, 2020 ; Willis et al, 2021 ), oxygen-Induced multi-organ disease ( Fernandez-Gonzalez et al, 2021 ), preeclamptic lung Injury ( Taglauer et al, 2022 ), various detrimental sequalae of hyperoxia exposure ( Reis et al, 2021 ), cornea disease ( McKay et al, 2021 ), hepatic fibrosis ( Rong et al, 2019 ), etc. In rat calvarial defects, miR-196a ( Qin et al, 2016 ), miR-27a, and miR-206 ( Lai et al, 2022 ) positively regulate the expression of osteogenic genes and osteoblast differentiation to stimulate bone formation ( Liu et al, 2018 ). In a mouse model of Alzheimer’s disease, miR-21 and miR-181c effectively reduced amyloid-β accumulation and increased synaptic protein expression and miR-21 levels in the brains of APP/PS1 mice ( Cui et al, 2018 ).…”